Zongshi Lu

Army Medical University

H指数:20

被引数:996

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative Outcomes of Adrenalectomy, Mineralocorticoid Receptor Antagonist, and Percutaneous Adrenal Ablation for Primary Aldosteronism: A Systematic Review and Network Meta-Analysis

肾上腺切除术、盐皮质激素受体拮抗剂和经皮肾上腺消融术治疗原发性醛固酮增多症的对比结局：一项系统评价和网络Meta分析

AMERICAN JOURNAL OF HYPERTENSION

IF3.1

2025-03-180

PRE

Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion

Roux-en-Y胃旁路手术诱导的肠道菌群改变通过增强肠道葡萄糖排泄实现降糖效果

GUT MICROBES

IF11

2025-03-030

OAAI

Meriones unguiculatus serves as a spontaneous primary aldosteronism rodent model

Meriones unguiculatus 可作为自发性原发性醛固酮增多症啮齿动物模型。

PLOS ONE

IF2.6

2025-02-130

Roux-en-Y gastric bypass alleviates kidney inflammation and improves kidney function in db/db mice by activating TLCA/TGR5 pathway

Roux-en-Y胃旁路术通过激活TLCA/TGR5通路缓解db/db小鼠的肾脏炎症并改善肾功能

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

IF3.1

2025-02-010

PRE

Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery

DIABETES OBESITY & METABOLISM

IF5.7

2024-06-251

PRE

Intestinal glucose excretion: A potential mechanism for glycemic control

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2024-03-011

PRE

Leptin receptor deficiency impedes metabolic surgery related-weight loss through inhibition of energy expenditure in db/db mice

DIABETOLOGY & METABOLIC SYNDROME

IF3.9

2024-02-010

OAAI

Artemisinin alleviates obesity-related glomerulopathy by downregulating CYP24A1 expression

DIABETES OBESITY & METABOLISM

IF5.7

2023-11-030

PRE

Cx43 acts as a mitochondrial calcium regulator that promotes obesity by inducing the polarization of macrophages in adipose tissue

CELLULAR SIGNALLING

IF3.7

2023-05-017

PRE

Mitochondrial dysfunction caused by SIRT3 inhibition drives proinflammatory macrophage polarization in obesity

OBESITY

IF4.7

2023-03-0913

OAAI

Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-01-309

OAAI

Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt-Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2022-08-0217

OAAI

Recurrent moderate hypoglycemia accelerates the progression of Alzheimer's disease through impairment of the TRPC6/GLUT3 pathway

JCI INSIGHT

IF6.1

2022-03-0821

OAAI

Low-glucose-sensitive TRPC6 dysfunction drives hypoglycemia-induced cognitive impairment in diabetes

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2020-10-1818

OAAI

Reducing NADPH Synthesis Counteracts Diabetic Nephropathy through Restoration of AMPK Activity in Type 1 Diabetic Rats

CELL REPORTS

IF6.9

2020-09-0115

OAAI

Activation of TRPV1 channel antagonizes diabetic nephropathy through inhibiting endoplasmic reticulum-mitochondria contact in podocytes

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2020-04-0175

PREAI

Inhibition of Mitochondrial Calcium Overload by SIRT3 Prevents Obesity- or Age-Related Whitening of Brown Adipose Tissue

DIABETES

IF7.5

2019-11-1191

OAAI

Impairment of Bitter Taste Sensor Transient Receptor Potential Channel M5-Mediated Aversion Aggravates High-Salt Intake and Hypertension

HYPERTENSION

IF8.2

2019-10-0117

OAAI

Caloric Restriction Exacerbates Angiotensin II-Induced Abdominal Aortic Aneurysm in the Absence of p53

HYPERTENSION

IF8.2

2019-03-0122

OAAI

TAURINE SUPPLEMENTATION IMPROVES VASCULAR FUNCTION IN PREHYPERTENSION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

JOURNAL OF HYPERTENSION

IF4.1

2018-10-010

PREAI

Zongshi Lu

个人简介

教育背景

工作经历

荣誉奖项

研究方向